Carlo Casulo

Nessuna posizione attualmente

Finance

Consumer Services

Health Technology

Profilo

Carlo Casulo worked as a Director of Technical Operations at Alaunos Therapeutics, Inc. in 2006.
He was an Analyst at Paramount BioCapital, Inc. in 2005 and at Ascend Capital LLC from 2008 to 2013.
He also worked as a Research Associate at Leerink Partners LLC from 2006 to 2008.
Dr. Casulo received his undergraduate degree from City University of New York in 2000.
He earned his doctorate degree from Harvard Medical School in 2006 and his MBA from Harvard Business School in 2005.

Precedenti posizioni note di Carlo Casulo

Società	Posizione	Fine
Leerink Partners LLC Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	28/02/2008
ALAUNOS THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	31/05/2006
Paramount BioCapital, Inc. Paramount BioCapital, Inc. Investment ManagersFinance Alternative investment manager	Corporate Officer/Principal	31/03/2005
Ascend Capital LLC Ascend Capital LLC Investment ManagersFinance Ascend Capital employs an opportunistic US-focused long/short equity investment strategy. They seek to generate superior risk-adjusted returns that maximize gains and minimize volatility over a broad range of market environments. They employ a variation of the Jones Model investing strategy with the intention of achieving capital appreciation in a broad range of market environments. The net market exposure of each account may vary significantly depending on the firm's assessment of shifting economic and market conditions, as well as particular long and short investing opportunities. Ascend Capital's strategy has neither a long nor short bias. Although their strategy focuses on equity and equity-related securities that are publicly traded, they may pursue a highly diverse range of investments and trading strategies. Ascend Capital may cause the accounts to invest a significant portion of their assets in one or more of the following: illiquid securities, including privately placed equity (of public and private companies), defaulted debt, bank debt and trade claims, bonds (convertible and non-convertible), other fixed-income investments and senior and subordinated tranches of asset-backed pools. Ascend Capital's strategy includes short selling. They expect the funds to utilize leverage on a moderate to extensive basis. The separate accounts utilize leverage in accordance with the investment guidelines for each account. The firm may cause the accounts to buy or sell (write) options, publicly traded and over-the-counter, covered and uncovered, on securities and securities indices, as well as options and forward contracts on currencies. They may also cause the accounts to engage in a variety of investment techniques involving arbitrage. addition, they may cause the accounts to engage in futures and other derivative transactions, typically for hedging of existing long and short positions.	Analyst-Equity	10/09/2013

Vedi nel dettaglio l'esperienza di Carlo Casulo

Formazione di Carlo Casulo

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Carlo Casulo

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	7
Ascend Capital LLC Ascend Capital LLC Investment ManagersFinance Ascend Capital employs an opportunistic US-focused long/short equity investment strategy. They seek to generate superior risk-adjusted returns that maximize gains and minimize volatility over a broad range of market environments. They employ a variation of the Jones Model investing strategy with the intention of achieving capital appreciation in a broad range of market environments. The net market exposure of each account may vary significantly depending on the firm's assessment of shifting economic and market conditions, as well as particular long and short investing opportunities. Ascend Capital's strategy has neither a long nor short bias. Although their strategy focuses on equity and equity-related securities that are publicly traded, they may pursue a highly diverse range of investments and trading strategies. Ascend Capital may cause the accounts to invest a significant portion of their assets in one or more of the following: illiquid securities, including privately placed equity (of public and private companies), defaulted debt, bank debt and trade claims, bonds (convertible and non-convertible), other fixed-income investments and senior and subordinated tranches of asset-backed pools. Ascend Capital's strategy includes short selling. They expect the funds to utilize leverage on a moderate to extensive basis. The separate accounts utilize leverage in accordance with the investment guidelines for each account. The firm may cause the accounts to buy or sell (write) options, publicly traded and over-the-counter, covered and uncovered, on securities and securities indices, as well as options and forward contracts on currencies. They may also cause the accounts to engage in a variety of investment techniques involving arbitrage. addition, they may cause the accounts to engage in futures and other derivative transactions, typically for hedging of existing long and short positions.	Finance
Paramount BioCapital, Inc. Paramount BioCapital, Inc. Investment ManagersFinance Alternative investment manager	Finance
Leerink Partners LLC Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
City University of New York City University of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alaunos Therapeutics, Inc. Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services